XWELL (NASDAQ:XWEL – Get Free Report) and Organon & Co. (NYSE:OGN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations.
Profitability
This table compares XWELL and Organon & Co.’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| XWELL | -51.85% | -352.37% | -64.88% |
| Organon & Co. | 3.01% | 122.01% | 6.74% |
Insider & Institutional Ownership
8.7% of XWELL shares are held by institutional investors. Comparatively, 77.4% of Organon & Co. shares are held by institutional investors. 13.9% of XWELL shares are held by insiders. Comparatively, 2.0% of Organon & Co. shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| XWELL | $29.21 million | 0.26 | -$16.85 million | ($5.11) | -0.26 |
| Organon & Co. | $6.22 billion | 0.26 | $187.00 million | $0.71 | 8.58 |
Organon & Co. has higher revenue and earnings than XWELL. XWELL is trading at a lower price-to-earnings ratio than Organon & Co., indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for XWELL and Organon & Co., as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| XWELL | 1 | 0 | 0 | 0 | 1.00 |
| Organon & Co. | 5 | 1 | 0 | 1 | 1.57 |
Organon & Co. has a consensus target price of $8.50, indicating a potential upside of 39.46%. Given Organon & Co.’s stronger consensus rating and higher probable upside, analysts plainly believe Organon & Co. is more favorable than XWELL.
Risk & Volatility
XWELL has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, Organon & Co. has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.
Summary
Organon & Co. beats XWELL on 11 of the 14 factors compared between the two stocks.
About XWELL
XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
About Organon & Co.
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with MarketBeat.com's FREE daily email newsletter.
